Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7YDG

Crystal structure of human SARS2 catalytic domain with a disease related mutation

Summary for 7YDG
Entry DOI10.2210/pdb7ydg/pdb
Related7YDF
DescriptorSerine--tRNA ligase, mitochondrial (1 entity in total)
Functional Keywordsmitochondrial seryl-trna synthetase, ligase
Biological sourceHomo sapiens (human)
Total number of polymer chains4
Total formula weight157639.31
Authors
Wu, S.,Li, P.,Zhou, X.L.,Fang, P. (deposition date: 2022-07-04, release date: 2022-11-02, Last modification date: 2023-11-29)
Primary citationYu, T.,Zhang, Y.,Zheng, W.Q.,Wu, S.,Li, G.,Zhang, Y.,Li, N.,Yao, R.,Fang, P.,Wang, J.,Zhou, X.L.
Selective degradation of tRNASer(AGY) is the primary driver for mitochondrial seryl-tRNA synthetase-related disease.
Nucleic Acids Res., 50:11755-11774, 2022
Cited by
PubMed Abstract: Mitochondrial translation is of high significance for cellular energy homeostasis. Aminoacyl-tRNA synthetases (aaRSs) are crucial translational components. Mitochondrial aaRS variants cause various human diseases. However, the pathogenesis of the vast majority of these diseases remains unknown. Here, we identified two novel SARS2 (encoding mitochondrial seryl-tRNA synthetase) variants that cause a multisystem disorder. c.654-14T > A mutation induced mRNA mis-splicing, generating a peptide insertion in the active site; c.1519dupC swapped a critical tRNA-binding motif in the C-terminus due to stop codon readthrough. Both mutants exhibited severely diminished tRNA binding and aminoacylation capacities. A marked reduction in mitochondrial tRNASer(AGY) was observed due to RNA degradation in patient-derived induced pluripotent stem cells (iPSCs), causing impaired translation and comprehensive mitochondrial function deficiencies. These impairments were efficiently rescued by wild-type SARS2 overexpression. Either mutation caused early embryonic fatality in mice. Heterozygous mice displayed reduced muscle tissue-specific levels of tRNASers. Our findings elucidated the biochemical and cellular consequences of impaired translation mediated by SARS2, suggesting that reduced abundance of tRNASer(AGY) is a key determinant for development of SARS2-related diseases.
PubMed: 36350636
DOI: 10.1093/nar/gkac1028
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (3.2 Å)
Structure validation

247536

PDB entries from 2026-01-14

PDB statisticsPDBj update infoContact PDBjnumon